MedTrace Logo

SUNBURST (Success Using Neuromodulation With BURST) Study

NCT02011893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 173

Last updated 2019-01-30

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to demonstrate the safety and efficacy of the Prodigy system for the treatment of chronic intractable pain of the trunk and/or limbs.

Conditions

Interventions

DEVICE

Tonic Stimulation

Prodigy Neurostimulation System with associated components

DEVICE

Burst Stimulation

Prodigy Neurostimulation System with associated components

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Timothy Deer, MD · The Center for Pain Relief

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2016-01-31
Completion
2017-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02011893 on ClinicalTrials.gov